supplier
Baxalta Limited
Only one published record mentions this organisation, so there is little to aggregate here yet. The notice itself carries the detail.
as a supplier
1 recorded award from 1 buyer , between 24 Nov 2017 and 24 Nov 2017.
“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.
No median is shown because every award here carries a framework ceiling rather than a settled price. A ceiling is the most that could be spent across every supplier on the agreement, so averaging them would overstate this organisation’s work, often by an order of magnitude. The individual values are listed below as published.
sells to
| buyer | awards |
|---|---|
| NHS England | 1 |
contracts won
| contract | buyer | value | awarded |
|---|---|---|---|
| National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders shared | NHS England | £302,000,000 | 24 Nov 2017 |